Filtered By:
Source: International Journal of Cardiology
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 880 results found since Jan 2013.
Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials
Up to half the patients with cryptogenic stroke under the age of 55 years have been found to have a PFO. Observational studies have demonstrated a benefit from closure of PFO and several RCTs have shown a trend toward benefit. The cost and clinical effectiveness of PFO closure is unclear.
Source: International Journal of Cardiology - July 21, 2018 Category: Cardiology Authors: Christopher A. Pickett, Todd C. Villines, Jon R. Resar, Edward A. Hulten Source Type: research
Cardiovascular events after ICU discharge in patients with new-onset atrial fibrillation: A report from the FROG-ICU study
We would like to thank Dr. Guenancia for suggesting a more detailed description of the major adverse cardiovascular and cerebrovascular events (MACCE, i.e. acute heart failure (AHF), myocardial infarction and stroke) occurring to the 1464 ICU survivors of the FROG-ICU cohort, to better understand the observed detrimental prognostic impact of atrial fibrillation (AFib) in critically ill patients [1, 2].
Source: International Journal of Cardiology - July 20, 2018 Category: Cardiology Authors: Mattia Arrigo, Elodie Feliot, Etienne Gayat, Alexandre Mebazaa Tags: Letter to the editor Source Type: research
Letter: Cardiovascular events after ICU discharge in patients with new-onset atrial fibrillation: A report from the FROG-ICU study
We would like to thank Dr. Guenancia for suggesting a more detailed description of the major adverse cardiovascular and cerebrovascular events (MACCE, i.e. acute heart failure (AHF), myocardial infarction and stroke) occurring to the 1464 ICU survivors of the FROG-ICU cohort, to better understand the observed detrimental prognostic impact of atrial fibrillation (AFib) in critically ill patients [1, 2].
Source: International Journal of Cardiology - July 20, 2018 Category: Cardiology Authors: Mattia Arrigo, Elodie Feliot, Etienne Gayat, Alexandre Mebazaa Tags: Letter to the editor Source Type: research
Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?
Non valvular atrial fibrillation (NVAF) is highly prevalent among chronic kidney disease (CKD) patients in whom it portends increased risk for subsequent stroke or systemic thromboembolic events. For these high risk patients oral anticoagulation is recommended, after proper assessment of both thromboembolic and bleeding risk is accurately ascertained.However, current NVAF risk scores are inadequate for use in CKD subjects, since they do not take into account the occurrence and the degree of renal function impairment.
Source: International Journal of Cardiology - July 15, 2018 Category: Cardiology Authors: Maura Ravera, Elisabetta Bussalino, Ernesto Paoletti, Antonio Bellasi, Luca Di Lullo, Maria Fusaro Source Type: research
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients
Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia, which is associated with an increased risk of stroke. Several studies have suggested that female AF patients could have a greater risk for stroke and thromboembolic events (TE).
Source: International Journal of Cardiology - July 9, 2018 Category: Cardiology Authors: Irene Marzona, Marco Proietti, Alessio Farcomeni, Giulio Francesco Romiti, Imma Romanazzi, Valeria Raparelli, Stefania Basili, Gregory Y.H. Lip, Alessandro Nobili, Maria Carla Roncaglioni Source Type: research
Importance of maintaining good oral health in cardiometabolic disorders
The association between periodontitis (Fig. 1), one of the most common bacterial-induced chronic inflammatory diseases in adults, and increased risk for atherosclerotic cardiovascular disease (CVD) is established, although the evidence that the treatment of periodontitis would reduce major adverse events is scarce and mainly circumstantial. Interestingly, Sen and co-workers [1] published recently that regular dental care was associated with decreased risk for incident stroke compared to no dental care or episodic care only when symptoms arise.
Source: International Journal of Cardiology - July 4, 2018 Category: Cardiology Authors: Pirkko J. Pussinen, Ernst Malle, Wolfgang Sattler Tags: Editorial Source Type: research
Evolving concepts in atrial fibrillation epidemiology: Advancing knowledge about cardiovascular health in sub-Saharan Africa
Atrial fibrillation (AF) is the most common cardiac arrhythmia presenting in the daily clinical practice [1]. In the last 50 years, AF prevalence and incidence have been shown to constantly increase, progressively becoming a worldwide healthcare issue, with relevant public health expenditure, both in terms of clinical management and consequences related to the main clinical adverse events related to AF (i.e. stroke, ma jor bleeding, cardiovascular events) [1,2].
Source: International Journal of Cardiology - July 4, 2018 Category: Cardiology Authors: Marco Proietti Tags: Editorial Source Type: research
Lowering the risk of stroke prevention: Managing bleeding complications
Oral anticoagulation is increasingly used, predominantly for thromboprophylaxis of atrial fibrillation and the prevention and treatment of venous thromboembolism. With an ageing population, increasing burden, and earlier recognition of atrial fibrillation, the number of patients taking oral anticoagulation is increasing year on year.
Source: International Journal of Cardiology - July 3, 2018 Category: Cardiology Authors: Diana A. Gorog Tags: Editorial Source Type: research
A systematic review of network meta-analyses among patients with Nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants
Direct oral anticoagulants (DOACs) are indicated for the prevention of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation. While no head-to-head randomized controlled trials (RCTs) exist that evaluate the efficacy and safety of DOACs, network meta-analyses (NMAs) based mainly on RCTs for each DOAC, and using varying methodologies, have been published. This systematic literature review summarizes the evidence on stroke/SE bleeding events, mortality, and other adverse events from NMAs that reported indirect comparisons of DOACs.
Source: International Journal of Cardiology - July 2, 2018 Category: Cardiology Authors: A. Cohen, N.R. Hill, X. Luo, C. Masseria, S.A. Abariga, A.O. Ashaye Source Type: research
Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort study
Atrial fibrillation (AF) increases the risk of stroke and mortality. However, rhythm control strategy did not reduce cardiovascular risks in short-term studies. We hypothesize that rhythm control better prevents stroke and mortality than rate control in AF patients over a long-term period.
Source: International Journal of Cardiology - June 26, 2018 Category: Cardiology Authors: Chi-Jen Weng, Cheng-Hung Li, Ying-Chieh Liao, Che-Chen Lin, Jiunn-Cherng Lin, Shih-Lin Chang, Chu-Pin Lo, Kuo-Ching Huang, Jin-Long Huang, Ching-Heng Lin, Yu-Cheng Hsieh, Tsu-Juey Wu Source Type: research
Uninterrupted NOAC therapy in patients undergoing catheter ablation of atrial fibrillation: “Dual anticoagulant therapy” ready for primetime or systematic overtreatment?
Catheter ablation of atrial fibrillation (AF) appears as a very promising technique to reduce arrhythmia episodes in patients with AF [1]. The major adverse events of such procedures are bleeding complications and stroke. Therefore, several studies were performed to assess efficacy and safety of different oral anticoagulants like warfarin (VKA) and non-VKA oral anticoagulants (NOAC). NOAC therapy has been explored in patients with chronic AF and in patients undergoing antiarrhythmic procedures [2, 3].
Source: International Journal of Cardiology - June 13, 2018 Category: Cardiology Authors: Andreas Goette Tags: Editorial Source Type: research
Bayes syndrome: Improving risk stratification in chronic heart failure?
The progressive ageing of population is leading to a significant increase of the incidence of heart failure (HF), one of the epidemics of the 21th Century. In addition, atrial fibrillation (AF) is the most common arrhythmia in elderly patients, and is associated with a higher incidence of stroke and mortality. A significant association between HF and AF has been consistently described, and its combination increases morbidity and mortality.
Source: International Journal of Cardiology - June 13, 2018 Category: Cardiology Authors: Albert Ariza-Sol é, Carme Guerrero, Francesc Formiga Tags: Editorial Source Type: research
Taking a deeper insight into the burden of cardiac amyloidosis: Has 3D speckle tracking echocardiographic strain come of age?
Left ventricular hypertrophy (LVH) when physiological is adaptive and beneficial, pathological hypertrophy may be maladaptive because of inability to provide a stroke volume commensurate with a normal life at rest and during physical activities/exercise. Therefore, one of the most important mandates in cardiology practice today is to differentiate between physiological and pathological hypertrophy.
Source: International Journal of Cardiology - June 11, 2018 Category: Cardiology Authors: Samir Kanti Saha, Anatoli Kiotsekoglou Tags: Editorial Source Type: research
Improved survival and reduced stroke risk in patients with atrial fibrillation: Is catheter ablation winning the rhythm-control race?
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with increased thromboembolic risk and mortality [1]. Catheter ablation as a strategy in managing this complex arrhythmia is generally reserved for symptomatic patients who are intolerant or refractory to anti-arrhythmic drugs for symptom control [2]. Indeed, catheter ablation has been repeatedly shown to be effective in improving symptom control and quality of life although the lack of “hard” endpoints to date is well recognized.
Source: International Journal of Cardiology - June 8, 2018 Category: Cardiology Authors: Kadhim Kadhim, Dennis H. Lau, Dominik Linz, Prashanthan Sanders Tags: Editorial Source Type: research
Patent foramen ovale after cryptogenic stroke: When is it justifiable to close it?
The incidence of patent foramen ovale (PFO) has been reported as high as 27% [1]. A strong association between cryptogenic stroke and PFO suggested that paradoxical embolism may be the culprit for such unexplained strokes. Several pathophysiological hypotheses have been proposed to explain paradoxical embolism: right ventricular dysfunction or decreased compliance, preferential flow from the inferior vena cava through the PFO, sometimes associated with an exuberant Eustachian valve or clot formation within an aneurysmal septum [2].
Source: International Journal of Cardiology - June 8, 2018 Category: Cardiology Authors: Alain Fraisse, Giovanni di Salvo, John C. Janssen, Sonya V. Babu-Narayan, Michael A. Gatzoulis Tags: Editorial Source Type: research
